NEW YORK (GenomeWeb) – NGX Bio said today that it has raised $3 million, which it will use to further develop its business brokering deals between customers seeking next-generation sequencing and the facilities that provide it.

The funding round was led by 180 Degree Capital, and included Third Kind Venture Capital, Lateral Capital, the Band of Angels, and the Berkeley Angel Network, among others.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.